TABLE 1.
Demographics and other clinical data for the patients with pneumococcal pneumonia in this study
| Parameter | Patient treatment
|
P | |
|---|---|---|---|
| Levofloxacin (n = 16) | Ceftriaxone (n = 16) | ||
| No. of males (%) | 7 (43.8) | 9 (56.3) | 0.3 |
| Mean age in yr (SD) | 70.3 (14.3) | 64.8 (18.8) | 0.7 |
| Age range (yr) | 34-85 | 19-89 | |
| No. of community-acquired cases (%) | 15 (93.8) | 15 (93.8) | 0.7 |
| Mean time (h) from pneumonia onset to inclusion (SD) | 53.75 (47.5) | 61.6 (49.6) | 0.7 |
| Time (h) from pneumonia onset to inclusion (range) | 4-168 | 3-144 | |
| No. of patients receiving previous statin therapy/total no. of patients (%) | 3/15 (20) | 1/16 (6.3) | 0.3 |
| No. of patients with history of acute use of nonsteroidal anti-inflammatory agents/total no. of patients (%) | 3/16 (18.8) | 3/16 (18.8) | 1 |
| No. of patients with history of acute concomitant corticosteroid therapy (%) | 9 (56.3) | 4 (25) | 0.14 |
| Mean dose of prednisone in mg (SD) | 131 (182) | 56 (123) | 0.1 |
| No. of patients in a long-term care facility (%) | 1 (6.3) | 0 | 0.3 |